Completed
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases
NCT02616393
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
- Locations
-
- Beverly Hills Cancer Center Beverly Hills, California, United States
- USC Norris Oncology/Hematology Newport Beach Newport Beach, California, United States
- John Wayne Cancer Institute Santa Monica, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States